Bortezomib will increase the stage or effect of flibanserin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of. Amplified flibanserin adverse results may well manifest if coadministered with a number of weak CYP3A4 inhibitors. Critical: The drug info on this web page is meant being instructional. It's not at https://nicholasz211nzk5.activosblog.com/profile